# Autonomix Medical, Inc.: filings

AMIX · Nasdaq · CIK 1617867 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/amix.md) · [Financials](/companies/amix/financials.md) · [Filings](/companies/amix/filings.md) · [Insiders](/companies/amix/insiders.md)

## Reports and events: 55 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 31, 4 15, 3 9, 10-Q 8, CORRESP 8, EFFECT 8, UPLOAD 6, 424B3 5, D 4, S-3 4, 10-K 3, 10-K/A 3, 1-A/A 3, 253G2 3, 424B5 3, DEF 14A 3, DEFA14A 3, PRE 14A 3, S-1 3, SC 13G 3, SCHEDULE 13G/A 3, QUALIF 2, S-1/A 2, S-8 2, SC 13D 2, 1-A 1, 1-A POS 1, 1-SA 1, 424B4 1, 8-A12B 1, CERT 1, DRS 1, POS AM 1, S-3/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-16 | 12:35 ET | [8-K](/filings/0001437749-26-030505.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-030505 |
| 2026-09-14 | 21:02 ET | [DEF 14A](/filings/0001437749-26-030345.md) | Proxy statement, period 2026-10-29 | 0001437749-26-030345 |
| 2026-08-26 | 21:02 ET | [8-K](/filings/0001437749-26-029024.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-029024 |
| 2026-08-13 | 23:40 ET | [10-Q](/filings/0001437749-26-027429.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027429 |
| 2026-07-28 | 15:36 ET | [8-K](/filings/0001437749-26-024597.md) | 8.01 Other events | 0001437749-26-024597 |
| 2026-07-15 | 21:02 ET | [8-K](/filings/0001437749-26-023638.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-023638 |
| 2026-07-10 | 12:32 ET | [8-K](/filings/0001437749-26-023248.md) | 8.01 Other events | 0001437749-26-023248 |
| 2026-06-24 | 11:00 ET | [8-K](/filings/0001437749-26-021495.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-021495 |
| 2026-06-15 | 21:28 ET | [10-K/A](/filings/0001437749-26-020686.md) | Annual report, amended, period 2026-03-31 | 0001437749-26-020686 |
| 2026-05-27 | 20:30 ET | [10-K](/filings/0001437749-26-018573.md) | Annual report, period 2026-03-31 | 0001437749-26-018573 |
| 2026-02-11 | 22:00 ET | [10-Q](/filings/0001437749-26-003816.md) | Quarterly report, period 2025-12-31 | 0001437749-26-003816 |
| 2026-01-16 | 12:30 ET | [8-K](/filings/0001437749-26-001381.md) | 3.01 Delisting notice | 0001437749-26-001381 |
| 2026-01-09 | 14:11 ET | [8-K](/filings/0001437749-26-000937.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-000937 |
| 2025-11-19 | 21:15 ET | [8-K](/filings/0001437749-25-035733.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-25-035733 |
| 2025-11-12 | 22:16 ET | [10-Q](/filings/0001437749-25-034517.md) | Quarterly report, period 2025-09-30 | 0001437749-25-034517 |
| 2025-11-03 | 22:00 ET | [8-K](/filings/0001437749-25-032798.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-032798 |
| 2025-09-23 | 21:14 ET | [S-1](/filings/0001437749-25-029750.md) | Registration statement | 0001437749-25-029750 |
| 2025-09-12 | 20:45 ET | [DEF 14A](/filings/0001437749-25-028954.md) | Proxy statement, period 2025-10-30 | 0001437749-25-028954 |
| 2025-09-03 | 21:01 ET | [S-1/A](/filings/0001437749-25-028296.md) | Registration statement, amended | 0001437749-25-028296 |
| 2025-08-27 | 21:16 ET | [8-K](/filings/0001437749-25-027890.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-027890 |
| 2025-08-26 | 10:30 ET | [8-K](/filings/0001437749-25-027719.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-25-027719 |
| 2025-08-20 | 21:03 ET | [S-1](/filings/0001437749-25-027461.md) | Registration statement | 0001437749-25-027461 |
| 2025-08-13 | 21:01 ET | [10-Q](/filings/0001437749-25-026564.md) | Quarterly report, period 2025-06-30 | 0001437749-25-026564 |
| 2025-07-28 | 21:02 ET | [10-K/A](/filings/0001437749-25-023669.md) | Annual report, amended, period 2025-03-31 | 0001437749-25-023669 |
| 2025-07-22 | 21:02 ET | [8-K](/filings/0001437749-25-023246.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-023246 |
| 2025-05-29 | 21:00 ET | [10-K](/filings/0001437749-25-018831.md) | Annual report, period 2025-03-31 | 0001437749-25-018831 |
| 2025-04-30 | 12:15 ET | [8-K](/filings/0001437749-25-013631.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-013631 |
| 2025-02-28 | 21:45 ET | [8-K](/filings/0001437749-25-005739.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-005739 |
| 2025-02-13 | 13:00 ET | [8-K](/filings/0001437749-25-003673.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-003673 |
| 2025-02-13 | 12:45 ET | [10-Q](/filings/0001437749-25-003669.md) | Quarterly report, period 2024-12-31 | 0001437749-25-003669 |
| 2025-01-22 | 21:03 ET | [8-K](/filings/0001437749-25-001558.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-001558 |
| 2024-11-25 | 22:12 ET | [8-K](/filings/0001437749-24-036182.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-036182 |
| 2024-11-12 | 21:02 ET | [S-1/A](/filings/0001437749-24-034531.md) | Registration statement, amended | 0001437749-24-034531 |
| 2024-11-12 | 13:00 ET | [8-K](/filings/0001437749-24-034326.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-034326 |
| 2024-11-08 | 22:00 ET | [10-Q](/filings/0001437749-24-034230.md) | Quarterly report, period 2024-09-30 | 0001437749-24-034230 |
| 2024-11-04 | 22:09 ET | [8-K](/filings/0001437749-24-033163.md) | 8.01 Other events | 0001437749-24-033163 |
| 2024-11-01 | 13:03 ET | [S-1](/filings/0001437749-24-032896.md) | Registration statement | 0001437749-24-032896 |
| 2024-10-28 | 10:01 ET | [8-K](/filings/0001437749-24-032175.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-032175 |
| 2024-10-17 | 21:20 ET | [8-K](/filings/0001437749-24-031491.md) | 5.07 Shareholder vote results | 0001437749-24-031491 |
| 2024-09-20 | 20:17 ET | [8-K](/filings/0001437749-24-029752.md) | 3.01 Delisting notice | 0001437749-24-029752 |
| 2024-09-04 | 22:27 ET | [DEF 14A](/filings/0001437749-24-028431.md) | Proxy statement, period 2024-10-17 | 0001437749-24-028431 |
| 2024-08-13 | 21:00 ET | [10-Q](/filings/0001437749-24-026451.md) | Quarterly report, period 2024-06-30 | 0001437749-24-026451 |
| 2024-08-13 | 12:15 ET | [8-K](/filings/0001437749-24-026162.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-026162 |
| 2024-07-26 | 21:14 ET | [10-K/A](/filings/0001437749-24-023626.md) | Annual report, amended, period 2024-03-31 | 0001437749-24-023626 |
| 2024-07-15 | 12:15 ET | [8-K](/filings/0001437749-24-022711.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-022711 |
| 2024-06-21 | 21:22 ET | [8-K](/filings/0001437749-24-021003.md) | 5.02 Departure or appointment of officers or directors | 0001437749-24-021003 |
| 2024-06-18 | 12:05 ET | [8-K](/filings/0001437749-24-020591.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-020591 |
| 2024-06-17 | 21:14 ET | [8-K](/filings/0001437749-24-020534.md) | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-020534 |
| 2024-05-31 | 20:56 ET | [10-K](/filings/0001437749-24-018932.md) | Annual report, period 2024-03-31 | 0001437749-24-018932 |
| 2024-05-31 | 20:45 ET | [8-K](/filings/0001437749-24-018924.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-018924 |

Page 1 of 2. [Older](/companies/amix/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.